first glp 1 agonist Evolution of GLP‐1 Receptor Agonists for Diabetes Treatment Victoza: The First Generic GLP-1

Related: Who May Be at Higher Risk Higher-risk individuals may include: patients with prior GI disorders individuals prone to dehydration people with kidney disease patients with diabetes-related vascular disease older adults long-term GLP-1 users Saxenda and Lawsuits Saxenda is included in broader GLP-1 litigation , particularly claims involving: severe motility disorders kidney injury gallbladder surgery pancreatitis permanent digestive injury blindness / NAION Saxenda lawsuits hub: Lawsuits When to Consider a Review You may want to consider review if: you used Saxenda, AND you required ER care or hospitalization, OR you developed a diagnosed complication, OR symptoms persisted after stopping the drug Start here: File a Claim Saxenda is an established weight-loss GLP-1 medication that can help reduce appetite and body weight, but it may also cause serious and persistent side effects in some patients

It helps signal fullness, supports insulin release, slows stomach emptying, and helps regulate blood sugar

doi: 10.5812/nephropathol.9093

Bucheit, J

however, incidence of this adverse event in clinical trials was very low [21]